Cargando…
Should oncologists trust cannabinoids?
Cannabis enjoyed a “golden age” as a medicinal product in the late 19th, early 20th century, but the increased risk of overdose and abuse led to its criminalization. However, the 21st century have witnessed a resurgence of interest and a large body of literature regarding the benefits of cannabinoid...
Autores principales: | Creanga-Murariu, Ioana, Filipiuc, Leontina Elena, Cuciureanu, Magda, Tamba, Bogdan-Ionel, Alexa-Stratulat, Teodora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373070/ https://www.ncbi.nlm.nih.gov/pubmed/37521486 http://dx.doi.org/10.3389/fphar.2023.1211506 |
Ejemplares similares
-
Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?
por: Filipiuc, Leontina Elena, et al.
Publicado: (2021) -
The Roles of Imaging Biomarkers in the Management of Chronic Neuropathic Pain
por: Pricope, Cosmin Vasilica, et al.
Publicado: (2022) -
The Skin and Natural Cannabinoids–Topical and Transdermal Applications
por: Filipiuc, Silviu-Iulian, et al.
Publicado: (2023) -
In Vitro Modeling of the Blood–Brain Barrier for the Study of Physiological Conditions and Alzheimer’s Disease
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022) -
Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy
por: Tamba, Bogdan Ionel, et al.
Publicado: (2020)